Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Narrative Review of the Psychiatric Aspects of Deep-Brain Stimulation for Movement Disorders: A Role for Consultation-Liaison Psychiatrists.

Journal of the Academy of Consultation-Liaison Psychiatry·2026
Same author

Determinants of Deep Brain Stimulation Candidacy Failure in Movement Disorders: A Multidisciplinary Analysis.

Movement disorders clinical practice·2026
Same author

Exposure to Air Pollutants and Lewy Body and Parkinson Disease-Related Dementias.

JAMA network open·2026
Same author

General Hospital Psychiatry: Serving the cause of reuniting the brain, mind and body.

General hospital psychiatry·2026
Same author

Neuropsychiatric symptoms in behavioral variant frontotemporal dementia: a narrative review.

International review of psychiatry (Abingdon, England)·2025
Same author

Neurofilament Light Chain and Differentiation of Behavioral Variant Frontotemporal Dementia From Psychiatric Disorders: A Systematic Review.

JAMA psychiatry·2025

Related Experiment Video

Updated: Jul 9, 2026

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

Electroconvulsive therapy and antibiotics: a case report.

Irving M Reti1, Dimitry S Davydow

  • 1Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. imreti@jhmi.edu

The Journal of ECT
|December 20, 2007
PubMed
Summary

Fluoroquinolone antibiotics, like moxifloxacin, may prolong electroconvulsive therapy (ECT) seizures. This class of drugs should be avoided in patients undergoing ECT to prevent extended seizure durations.

More Related Videos

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

Related Experiment Videos

Last Updated: Jul 9, 2026

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

Area of Science:

  • Neurology
  • Pharmacology
  • Infectious Diseases

Background:

  • Infections are frequent in hospitalized patients, often requiring antibiotic treatment.
  • Electroconvulsive therapy (ECT) is a medical procedure used for specific psychiatric conditions.
  • Managing comorbidities during ECT requires careful consideration of potential drug interactions.

Observation:

  • A case study involving an 82-year-old woman undergoing ECT is presented.
  • The patient was treated with moxifloxacin, a fluoroquinolone antibiotic, for a respiratory infection.
  • Previously, the patient tolerated ECT without complications.

Findings:

  • Introduction of moxifloxacin was associated with a significant prolongation of electroconvulsive seizure duration.
  • The prolonged seizure duration occurred despite the successful treatment of the patient's respiratory infection.
  • This observation aligns with existing evidence suggesting fluoroquinolones can lower the seizure threshold.

Implications:

  • Fluoroquinolone antibiotics may pose a risk for patients undergoing ECT due to their effect on seizure threshold.
  • Clinicians should exercise caution and consider alternative antibiotics in patients receiving ECT.
  • Further research is warranted to fully elucidate the interaction between fluoroquinolones and ECT.